Search results for "From ACP Internist"


 
Results 11 - 20 of about 85 for "From ACP Internist".
Sort by: Relevance | Newest | Oldest

ACE inhibitors, ARBs most effective against ESRD in patients with diabetes, kidney disease

Angiotensin-converting enzyme (ACE) inhibitors and angiotensin-receptor blockers (ARBs) appear most effective in preventing end-stage renal disease (ESRD) in patients with diabetes and kidney disease, although no regimen to lower blood pressure seems to prolong survival, a recent analysis has found.
https://diabetes.acponline.org/archives/2015/06/12/7.htm
12 Jun 2015

Task Force releases systematic review about diabetes screening

A systematic evidence review by the U.S. Preventive Services Task Force suggests that screening asymptomatic adults for elevated glucose levels could help delay progression to diabetes but has not been shown to improve mortality rates.
https://diabetes.acponline.org/archives/2015/06/12/6.htm
12 Jun 2015

Diabetes Collaborative Registry seeks primary care participants

ACP has partnered with the American College of Cardiology to participate in the Diabetes Collaborative Registry, a national clinical diabetes registry and interdisciplinary collaboration designed to assess and improve the quality of a practice's diabetes care for free.
https://diabetes.acponline.org/archives/2015/08/14/8.htm
14 Aug 2015

Weight loss, improvement in comorbid conditions after laparoscopic sleeve gastrectomy appear to decline with time, study finds

Bariatric surgery with laparoscopic sleeve gastrectomy (LSG) improves weight loss and comorbid conditions related to obesity in the short term, but its effects decline over the long term, according to a new study.
https://diabetes.acponline.org/archives/2015/08/14/7.htm
14 Aug 2015

Troponin concentration may help stratify risk in those with stable ischemic heart disease and diabetes

Researchers used a high-sensitivity assay to measure cardiac troponin T concentration at baseline, then analyzed whether it was associated with a composite end point (death from cardiovascular causes, myocardial infarction, or stroke).
https://diabetes.acponline.org/archives/2015/09/11/5.htm
11 Sep 2015

Task Force recommends screening for type 2 diabetes in overweight, obese adults

The U.S. Preventive Services Task Force now recommends screening for abnormal blood glucose as part of cardiovascular risk assessment in overweight and obese adults ages 40 to 70 years.
https://diabetes.acponline.org/archives/2015/11/13/8.htm
13 Nov 2015

Physicians may overtreat blood pressure, glucose in older patients with diabetes

A retrospective cohort study used data from the Department of Veterans Affairs to assess both hypertension and blood glucose medication deintensification (i.e., dosage reduction or withdrawal of a drug).
https://diabetes.acponline.org/archives/2015/11/13/7.htm
13 Nov 2015

No clear-cut choice among once-weekly GLP-1 receptor agonists

All once-weekly GLP-1 receptor agonists reduced HbA1c and fasting plasma glucose levels, and either no differences or clinically marginal differences were found among the drugs for blood pressure, blood lipid levels, and C-reactive protein levels, according to the systematic review and network meta-analysis.
https://diabetes.acponline.org/archives/2015/12/11/6.htm
11 Dec 2015

Antihypertensives associated with worse outcomes in diabetic patients with lower SBP

Blood pressure treatment goals should be less aggressive in people with diabetes than without diabetes, study authors said, because if systolic blood pressure (SBP) is already less than 140 mm Hg, additional agents might be harmful.
https://diabetes.acponline.org/archives/2016/03/11/7.htm
11 Mar 2016

Score may help predict which patients are likely to achieve type 2 diabetes cure after bariatric surgery

DiaRem, a weighted score ranging from 0 to 22 points, is based on age, insulin dependence, diabetes medication use, and HbA1c level.
https://diabetes.acponline.org/archives/2016/05/13/6.htm
13 May 2016

Result Page: Prev   1   2   3   4   5   6   7   8   9   Next